Ok, guys ... when talking stems the other day, I didn't even bring this one up because of all of the share overhang, legal battles, etc. BUT, and a big BUT...they have the most incredible trials going on for macular degeneration and look at the news today. From 20/400 to 20/40 after treatment? Yowza!
Bought 200K this a.m. Been following them for YEARS!!!!
I am holding 4k shares of STEM who are also working on dry macular degeneration as well as alzheimer and nerve regeneration in paraplegics. Whatever came ut on ACTC is spilling over into STEM which is at resistance at 1.91. The difference between the two charts is the 200 day moving average. It is likely to #$%$ any short term move in actc just like you saw in ALXA which is a good daily chart to compare. It broke out above the 200 dma and got beat back to the 20dma. But that's trading short to intermediate term, not long term investing. Good luck with your investment.